Page last updated: 2024-08-25

sofosbuvir and uridine triphosphate

sofosbuvir has been researched along with uridine triphosphate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Amblard, F; Bassit, LC; Cho, JH; Coats, SJ; De Schutter, C; Domaoal, RA; Ehteshami, M; Jiang, Y; Kasthuri, M; Lee, S; Lin, BY; McBrayer, T; Mengshetti, S; Ollinger Russell, O; Ovadia, R; Pascual, ML; Pattassery, J; Sari, O; Schinazi, RF; Tao, S; Uher, L; Verma, K; Whitaker, T; Zhang, H; Zhou, L1
Colby-Germinario, SP; Fogarty, C; Han, Y; Hassounah, SA; Oliveira, M; Osman, N; Palanisamy, N; Quan, Y; Wainberg, MA; Xu, HT1
Elfiky, AA1

Other Studies

3 other study(ies) available for sofosbuvir and uridine triphosphate

ArticleYear
Discovery of a Series of 2'-α-Fluoro,2'-β-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus.
    Journal of medicinal chemistry, 2019, 02-28, Volume: 62, Issue:4

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; Deoxyribonucleosides; Deoxyuracil Nucleotides; Dogs; Drug Discovery; Enzyme Inhibitors; Hepacivirus; Humans; Male; Microsomes, Liver; Prodrugs; Viral Nonstructural Proteins

2019
Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication.
    Scientific reports, 2017, 07-24, Volume: 7, Issue:1

    Topics: Antiviral Agents; Cell Line; Dengue; Dengue Virus; Drug Evaluation; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Sofosbuvir; Uridine Triphosphate; Viral Nonstructural Proteins; Virus Replication

2017
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
    Life sciences, 2020, May-01, Volume: 248

    Topics: Adenosine Monophosphate; Alanine; Alphacoronavirus; Amino Acid Sequence; Antiviral Agents; Betacoronavirus; Catalytic Domain; Computational Biology; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Guanosine Monophosphate; Guanosine Triphosphate; Humans; Molecular Docking Simulation; Pneumonia, Viral; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Ribavirin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Sequence Alignment; Sequence Homology, Amino Acid; Sofosbuvir; Thermodynamics; Uridine Triphosphate; Viral Proteins

2020